Drugs.com - Pharma Industry News

Nanosensor Assay Promising for Pancreatic Cancer Detection

FRIDAY, Feb. 28, 2025 -- A rapid nanosensor assay that measures serum protease cleavage of a target-probe nanosensor can identify pancreatic ductal adenocarcinoma (PDAC) samples with high specificity and sensitivity, according to a study published...

Feb 28, 2025 - 18:55
 0
Nanosensor Assay Promising for Pancreatic Cancer Detection
FRIDAY, Feb. 28, 2025 -- A rapid nanosensor assay that measures serum protease cleavage of a target-probe nanosensor can identify pancreatic ductal adenocarcinoma (PDAC) samples with high specificity and sensitivity, according to a study published...
Read More

Tags:

Previous Article

Gynecological Disorders Can Increase Risk for Cardiovascular, Cerebrovascular Di...

Next Article

Uptake of Supportive Care Low for Patients With Advanced Cancer

Related Posts

Talazoparib + Enzalutamide Tied to Improved Overall Survival in Metastatic Prostate Cancer

Talazoparib + Enzalutamide Tied to Improved Overall Sur...

Feb 19, 2025  0

Elevated HDL Cholesterol Linked to Increased Risk for Glaucoma

Elevated HDL Cholesterol Linked to Increased Risk for G...

Feb 9, 2025  0

AI Improves Risk Prediction in Patients With Myelofibrosis Undergoing Allo-HCT

AI Improves Risk Prediction in Patients With Myelofibro...

Apr 4, 2025  0